Adaptive Biotechnologies Corp — Director's Dealing 2022

Jan 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2022-01-26

Reporting Person: Conroy Kevin T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-26	Common Stock	A	6689	$0.00	Acquired	8193	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-26	Stock Option (Right to Buy)	$14.95	A	16722	Acquired	2032-01-26	Common Stock (16722)	Direct

Footnotes

F1: The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.